Our results are justified by the hepcidin-25 levels: Group I patients (with anemia and the absence of inflammation) had lower levels of serum hepcidin-25 compared to Control group and Group II patients (predominant inflammation, minimal anemia). The gene discussed is HAMP; the disease is anemia (phenotype).